WOCKPHARMA.NS Cash Flow
Wockhardt Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:46
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹1.53 Bn | ₹2.19 Bn | ₹-0.22 Bn | ₹3.90 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-1.25 Bn | ₹-1.37 Bn | ₹-7.83 Bn | ₹-2.41 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-3.15 Bn | ₹3.34 Bn | ₹4.09 Bn | ₹-0.54 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.07 Bn | ₹-0.01 Bn | ₹0.03 Bn | ₹0.10 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-2.80 Bn | ₹4.15 Bn | ₹-3.93 Bn | ₹1.05 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹3.70 Bn | ₹0.90 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from WOCKPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).